Results 181 to 190 of about 18,617,874 (263)
Regulatory harmonization: Evolution, globalization and future directions
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm +2 more
wiley +1 more source
Talking placebo: a qualitative study of patients' attitudes toward open-label placebo implementation into clinical practice. [PDF]
Frey Nascimento A +8 more
europepmc +1 more source
The impact of pharmaceutical form and simulated side effects in an open-label-placebo RCT for improving psychological distress in highly stressed students. [PDF]
Winkler A, Hahn A, Hermann C.
europepmc +1 more source
Aims Golcadomide is a potential first‐in‐class oral CELMoD™ agent for the treatment of lymphoma. This study aims to develop model‐informed drug development (MIDD) approaches to support optimal dose selection of golcadomide in combination with immunotherapy rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R‐CHOP) in alignment with ...
Xirong Zheng +7 more
wiley +1 more source
Combining mindfulness intervention and open-label placebo treatment for chronic pain: a protocol for a feasibility study. [PDF]
Mun CJ +14 more
europepmc +1 more source
Aims This study aimed to evaluate the acute effects of cannabidiol plus tetrahydrocannabinol (CBD+THC) and tetrahydrocannabinol (THC) oils on cardiovascular haemodynamics, respiratory muscle activity and peripheral tissue perfusion in healthy adults. Methods In this randomized, double‐blind, crossover trial, participants received orally administered ...
Edna Karla Ferreira Laurentino +9 more
wiley +1 more source
Changes in neural processing and evaluation of negative facial expressions after administration of an open-label placebo. [PDF]
Schienle A, Unger I, Schwab D.
europepmc +1 more source
Gabapentin as an add‐on analgesic to morphine in paediatric patients with chronic pain
Aims Off‐label use of gabapentin for the treatment of chronic pain in children has increased over the last decade, with multiple clinical trials evaluating its role pain management and potential opioid‐sparing effects. To date, however, these studies appear to rely on empirical evidence without further consideration of pharmacokinetic‐pharmacodynamic ...
Paul Healy +15 more
wiley +1 more source

